Search Results 1621-1630 of 38836 for Two-phase

  1. Breast-Conserving Surgery and Radiation Therapy in Patients with Multiple Ipsilateral Breast Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL - Mayo Clinic

    This is a Phase 2 global, multi-center, open-label study to assess the ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and ...

  5. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  6. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. A Study to Evaluate the Safety and Effectiveness of the GORE® TAG® Thoracic Branch Endoprosthesis for Treating Lesions of the Aortic Arch and Chest Aorta - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  8. Something to Think About: Does Time Heal? - Mayo Clinic News Network

    The drama of life is hosted by two stages—the gross stage of the world and the subtle stage of the time. Time provides the scaffold for life to weave its ...

  9. Publications - Aaron S. Mansfield, M.D. - Mayo Clinic

    ... phase 1/2 study. Lancet Diabetes Endocrinol. 2021 Aug; 9 (8):491-501 Epub 2021 June 09. View PubMed; Shafique MR, Fisher TL, Evans EE, Leonard JE, Pastore DRE ...

  10. PF-04449913 Single-Agent In Patients with Myelofibrosis Previously Treated with a Janus Kinase Inhibitor - Mayo Clinic

    Following the lead-in, a phase 2, randomized, double blind, 2 arm study of oral single agent PF 04449913 versus placebo will be tested in patients resistant or ...